Opinions
Gordon Reid
Immucor Inc.
BLUD-Q
TOP PICK
Sep 10, 2008
Manufactures and develops agents for testing of human blood prior to blood transfusions. A lot of this was done manually but is now done through their technology. Growing very rapidly. Strong balance sheet. ROE’s of about 25%. Long-term growth rate of about 20%.
$31.980
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising